Key Record Dates
ClinicalTrials.gov Identifier: | NCT02447003 |
---|---|
Brief Title: | Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086) |
First Submitted : | May 14, 2015 |
First Submitted that Met QC Criteria : | May 14, 2015 |
First Posted : | May 18, 2015 (Estimate) |
Results First Submitted : | November 18, 2020 |
Results First Submitted that Met QC Criteria : | November 18, 2020 |
Results First Posted : | December 16, 2020 |
Last Update Submitted that Met QC Criteria : | November 18, 2020 |
Last Update Posted : | December 16, 2020 |